Pictet Asset Management (UK)’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $180M | Sell |
982,218
-582,521
| -37% | -$100M | 0.2% | 144 |
|
|
2021
Q1 | $239M | Sell |
1,564,739
-383,611
| -20% | -$59.3M | 0.29% | 101 |
|
|
2020
Q4 | $304M | Buy |
1,948,350
+134,303
| +7% | +$17.3M | 0.4% | 66 |
|
|
2020
Q3 | $208M | Sell |
1,814,047
-77,280
| -4% | -$8.34M | 0.33% | 91 |
|
|
2020
Q2 | $212M | Buy |
1,891,327
+733,740
| +63% | +$77.9M | 0.37% | 79 |
|
|
2020
Q1 | $104M | Buy |
1,157,587
+328,356
| +40% | +$32.2M | 0.22% | 131 |
|
|
2019
Q4 | $89.7M | Sell |
829,231
-96,535
| -10% | -$10.3M | 0.16% | 171 |
|
|
2019
Q3 | $90.7M | Sell |
925,766
-674,260
| -42% | -$76M | 0.19% | 145 |
|
|
2019
Q2 | $210M | Sell |
1,600,026
-248,438
| -13% | -$32M | 0.46% | 54 |
|
|
2019
Q1 | $250M | Buy |
1,848,464
+127,040
| +7% | +$15.8M | 0.56% | 32 |
|
|
2018
Q4 | $168K | Buy |
1,721,424
+27,997
| +2% | +$3.31M | 0.42% | 63 |
|
|
2018
Q3 | $235M | Sell |
1,693,427
-6,414
| -0.4% | -$805K | 0.5% | 43 |
|
|
2018
Q2 | $211M | Buy |
1,699,841
+127,840
| +8% | +$14.9M | 0.5% | 46 |
|
|
2018
Q1 | $175M | Buy |
1,572,001
+251,811
| +19% | +$30.1M | 0.43% | 60 |
|
|
2017
Q4 | $158M | Buy |
1,320,190
+193,915
| +17% | +$23.6M | 0.41% | 65 |
|
|
2017
Q3 | $158M | Buy |
1,126,275
+358,695
| +47% | +$48.7M | 0.45% | 55 |
|
|
2017
Q2 | $75.2M | Sell |
767,580
-35,286
| -4% | -$4.11M | 0.23% | 136 |
|
|
2017
Q1 | $97.3M | Buy |
802,866
+23,555
| +3% | +$3.04M | 0.32% | 90 |
|
|
2016
Q4 | $95.3M | Buy |
779,311
+39,303
| +5% | +$4.81M | 0.35% | 77 |
|
|
2016
Q3 | $90.7M | Buy |
740,008
+45,889
| +7% | +$5.91M | 0.34% | 80 |
|
|
2016
Q2 | $105M | Buy |
694,119
+359,851
| +108% | +$51.1M | 0.41% | 69 |
|
|
2016
Q1 | $47.1M | Buy |
334,268
+279
| +0.1% | +$41K | 0.21% | 131 |
|
|
2015
Q4 | $63.7M | Sell |
333,989
-25,097
| -7% | -$4.38M | 0.27% | 107 |
|
|
2015
Q3 | $56.2M | Buy |
359,086
+7,835
| +2% | +$1.43M | 0.25% | 111 |
|
|
2015
Q2 | $69.4M | Buy |
351,251
+98,956
| +39% | +$17.1M | 0.28% | 90 |
|
|
2015
Q1 | $42.7M | Buy |
252,295
+22,181
| +10% | +$4.01M | 0.18% | 157 |
|
|
2014
Q4 | $42.6M | Buy |
230,114
+61,706
| +37% | +$11.4M | 0.19% | 141 |
|
|
2014
Q3 | $27.9M | Sell |
168,408
-18,200
| -10% | -$2.99M | 0.13% | 190 |
|
|
2014
Q2 | $29.2M | Buy |
186,608
+15,200
| +9% | +$2.4M | 0.14% | 181 |
|
|
2014
Q1 | $26.1M | Sell |
171,408
-1,300
| -0.8% | -$207K | 0.13% | 182 |
|
|
2013
Q4 | $23M | Sell |
172,708
-12,700
| -7% | -$1.52M | 0.12% | 202 |
|
|
2013
Q3 | $21.5M | Sell |
185,408
-26,600
| -13% | -$2.92M | 0.12% | 197 |
|
|
2013
Q2 | $19.6M | Buy |
+212,008
| New | +$20.4M | 0.11% | 198 |
|
Other funds holding ALXN
FCM
HI
DKCM
PCM
UOC